Evidence map›Paper›PMID 42602540›Full record

ArticleCureus2026

Successful Management of Discordant Twin Growth in End-Stage Renal Disease: A Rare Case Report.

Maha Wazir, Farhan Ullah, Salem Almaani, Udayan Bhatt

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maha WazirNephrology, The Ohio State University Wexner Medical Center, Columbus, USA.
Farhan UllahNephrology, Ochsner Medical Center, New Orleans, USA.
Salem AlmaaniNephrology, The Ohio State University College of Medicine, Ohio, USA.
Udayan BhattNephrology, The Ohio State University Wexner Medical Center, Columbus, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes the successful management of a dichorionic-diamniotic twin pregnancy in a 35-year-old woman with end-stage renal disease (ESRD) on hemodialysis. The patient had established kidney failure secondary to presumed hypertensive nephrosclerosis, complicated by a previous pregnancy with preeclampsia, and was maintained on home hemodialysis (five hours per session on alternate days) since 2022. Upon confirmation of twin pregnancy, her dialysis regimen was immediately intensified from alternate-day sessions to daily treatments totaling 35 hours/week, with parameters including five-hour duration, blood flow rate of 250 mL/min, and ultrafiltration of 1.2-1.5 kg/session. During the second trimester, maternal weight was carefully monitored alongside fetal growth, with an expected increase of 0.5-1 kg weekly. At 27 weeks' gestation, significant fetal growth discordance prompted further dialysis intensification to six times weekly with increased blood and dialysate flow rates. The pregnancy was complicated by intrahepatic cholestasis and therapy-resistant hypertension. At 31 weeks, the patient developed acute pulmonary edema with severe preeclampsia features despite optimal volume management, requiring emergent cesarean delivery of two live infants. This case demonstrates that intensive dialysis protocols are essential for achieving favorable outcomes in twin pregnancies complicated by ESRD. Success depends on three critical components: early recognition of maternal and fetal complications, intensive fetal surveillance throughout pregnancy, and precise control of dialysis parameters with frequent adjustments based on clinical status and fetal development.

Indexed as

esrd on hdgrowth discordanceintensive hemodialysismultiple gestationpreeclampsiapregnancy in dialysisrenal failuretwin pregnancytwin pregnancy in esrd

Identifiers

PMID42602540
PMCPMC13475032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.